Home›Companies›Healthcare›Willow Life Sciences

Willow Life Sciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 6, 2025·Suggest an edit

About Willow Life Sciences

Willow Life Sciences is a private company based in Allston, Massachusetts, incorporated in 2023 in Delaware. It has reported $4,000,000 raised in one offering on Form D since November 2025. Its chief executive is Morgan Moncada.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 29, 2025Nov 6, 2025$4,000,000fully sold19$210KEquity, Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Willow Life Sciences's Form D filed Nov 6, 2025.

MM
Morgan Moncada
Chief Executive Officer and director

Sources

  1. SECWillow Life Sciences, Inc. filing history